In today’s marketplace there are very few business strategies that do not include technology transfer as part of the competitive landscape. Whether driven through consolidation, in/out-licensing or outsourcing, the ability to effectively transfer and commercialize a product can mean the difference between keeping or taking marketshare. Legacy products in particular represent significant technical challenges in technology transfer because historical development data may not be adequate to support the new Stage 1 process validation requirements and must be integrated as part of the technology transfer plan.
To read the full, original article click on this link: The Four Pillars of Technology Transfer | Pharmaceutical Processing
